CPRX
Catalyst Pharmaceuticals, Inc.Company with tickers: CPRX
CIK
1369568
CUSIP
14888U101
Shares Outstanding
122,380,992
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $149,390,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $51,980,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Research & Development | $2,661,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Operating Income | $73,232,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Net Income | $63,734,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| EPS (Basic) | $0.52 | USD/shares | 2026-03-31 | 10-Q | 2026-05-11 |
| EPS (Diluted) | $0.50 | USD/shares | 2026-03-31 | 10-Q | 2026-05-11 |